Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Thermogelled HPMC Dissolves Better

By Drug Discovery Trends Editor | October 23, 2012

New data show that plant-based capsules made from hypromellose, manufactured using a thermal gelling process instead of one with gelling agents, have a faster and more predictable dissolution profile that is independent of the dissolution media.

“Today’s findings confirm that plant-based HPMC capsules can be manufactured to produce consistent rates of dissolution independent of the dissolution media relative to both pH or cation nature and content while also providing a stable environment for moisture-sensitive ingredients,” said Dominique Cade, PhD, who presented today’s poster titled “Hypromellose Hard Capsules Dissolution.” Dr. Cade is the Director of Polymer Science for the Research and Development department at Capsugel. “This is an important proof of concept in alternate polymer science that will benefit current and future products requiring gelatin-like performance in an alternate polymer.”

In the study, researchers compared the in vitro dissolution performance of commercially available HPMC hard capsules using different media.  The test results reveal that with a pH1.2 USP medium, the simple switch from 2 g NaCl/L to 2 g KCl/L causes a significant delay in the dissolution of capsules with kappa-carrageenan, the most commonly used gelling system. For the Hypromellose capsules manufactured with carrageenan as a gelling agent, the quantity of caffeine released after 30 minutes was less than 50% in comparison to hypromellose capsules manufactured without a gelling agent which released more than 90% in the same time period. The same change occurred when using the simulated milk fluid: the release after 30 minutes was less than 30% compared to more than 90% for the HPMC without the gelling system.

Gelatin capsules are produced by dipping a mold pin into hot liquid gelatin.  The HPMC polymer has reasonable flexibility and with the use of a secondary gelling agent, capsule manufacturers can generate quick setting HPMC. An issue with the use of secondary gelling systems is that they can interact with dissolution media causing delayed drug release that may be undesirable during product development.  “It is well established that the gelling of carrageenan is strongly enhanced by some cations, notably potassium and calcium.  Within the stomach, the presence of foods containing potassium or calcium could cause an interaction that would delay or change the product release,” Cade concluded.

To develop an HPMC capsule without using a gelling agent, Capsugel scientists assessed the impact of the mold pin temperature and conditions to achieve optimal capsule drying.  From these studies, a proprietary thermal gelling process was developed that eliminated the need to use a gelling agent and salts as co-gelling agents.  The resulting capsules are known as Vcaps Plus capsules.

Date: October 17, 2012
Source: Capsugel


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50